Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Selected Proceedings of the European Society for Clinical Hemorheology (E.S.C.H.), 26–29 June, 2005, Siena, Italy
Article type: Research Article
Authors: Baskurt, O.K.; | Yalcin, O. | Gungor, F. | Meiselman, H.J.
Affiliations: Department of Physiology, Akdeniz University Faculty of Medicine, Antalya, Turkey | Department of Nuclear Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey | Department of Physiology and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Note: [] Corresponding author: Oguz K. Baskurt, Department of Physiology, Akdeniz University Faculty of Medicine, Kampus, Antalya 07070, Turkey. Tel.: +90 242 310 1560; Fax: +90 242 310 1561; E-mail: baskurt@akdeniz.edu.tr.
Abstract: It is well known that the hematocrit in microvessels with diameters smaller than 1000 μm is lower than either venous or arterial hematocrit, thereby resulting in significantly lower mean hematocrit values for vessels perfusing a given tissue (i.e., lower tissue hematocrit). The mechanisms that underlie this reduction of microvascular hematocrit include axial migration, plasma skimming and the Fahraeus Effect. It has been previously demonstrated in rats that a linear hematocrit gradient normally exists through the thickness of the left ventricular myocardium, and that this gradient is sensitive to alterations of the rheological properties of the circulating blood. The gradient is abolished if the RBC in the perfusate are rigid; fibrinogen infusions, and thus increases of both plasma viscosity and RBC aggregation, also affect this gradient. In a new series of studies, it has been observed that enhanced RBC aggregation affects the myocardial hematocrit gradient regardless of alterations of plasma viscosity. Although the exact mechanisms responsible for the myocardial hematocrit gradient, as well as its physiological significance, are not yet clearly known, it is possible to speculate that alterations in local hematocrit could adversely affect myocardial perfusion and function.
Keywords: Tissue hematocrit, microvascular hematocrit, erythrocyte deformability, erythrocyte aggregation
Journal: Clinical Hemorheology and Microcirculation, vol. 35, no. 1-2, pp. 45-50, 2006
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl